Skip to content

Current ratio at other companies

Abbott logo
AbbottABT
1.4×-0.4×
Johnson & Johnson logo
Johnson & JohnsonJNJ
-0.2×
Boston Scientific logo
Boston ScientificBSX
1.9×+0.4×
Medtronic logo
MedtronicMDT
2.1×+0.3×
Merit Medical Systems logo
Merit Medical SystemsMMSI
5.1×+0.2×
ITG
Integer HoldingsITGR
3.8×+0.4×

Other financials

Income statement

See full
Revenue$401.0K
Gross profit$31.0K
Operating income-$19.2M-6.1%
Net income-$18.6M-10.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$68.3M-42.7%
Total debt$7.2M-16.6%
Total equity$66.3M-44.0%
Total assets$81.6M-38.8%

Cash flow

See full
Operating cash flow-$14.6M-7.9%
CapEx$33.0K-26.7%
Free cash flow-$14.6M-7.8%

Valuation

See full
Market cap$1.8B+38.4%
Enterprise value$1.73B+48.1%
P/S2,391.5×

Profitability

See full
Gross margin-4,067.5%
Operating margin-10,392.1%
Net margin-9,929%
FCF margin-7,390%

Returns & leverage

See full
Return on equity-80.7%+3.1pp
Debt / equity0.1×0.0×

Where this comes from

Calculated from Pulse Biosciences, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s current ratio?
Pulse Biosciences, Inc. (PLSE) reported current ratio of 7.3× in Q1 2026.
How has Pulse Biosciences, Inc.'s current ratio changed year-over-year?
Pulse Biosciences, Inc.'s current ratio decreased by 53.4% year-over-year, from 15.6× to 7.3×.
What is the long-term trend for Pulse Biosciences, Inc.'s current ratio?
Over 5 years (2020 to 2025), Pulse Biosciences, Inc.'s current ratio has grown at a 29.0% compound annual growth rate (CAGR), from 2.9× to 10.5×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.